S2001, Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 Mutations
Details
Age
Adult
Type of Study
Treatment
Locations
Cherry Creek Medical Center
Greeley Campus
Harmony Campus
Highlands Ranch Hospital
Medical Center of the Rockies
Poudre Valley Hospital
University of Colorado Hospital
Principal Investigator
Sunnie Kim, MD
Study ID
Protocol Number: 21-3607
More information available at ClinicalTrials.gov: NCT04548752
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers